Locations:
Search IconSearch

Cancer

23-CNR-4044609-CQD-Hero-650×450 AML study
October 20, 2023/Cancer/Research

The Role of Immune Escape in Post-Transplant Leukemia Relapse

Immunological pressure driving genetic mutations

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight

Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4162210-CQD-Hero-650×450 Dr Khorana
October 12, 2023/Cancer/Research

Study Delves into the Mechanisms Causing Venous Thromboembolism in Patients Receiving Immunotherapies

Clinicians highlight the need to educate patients about warning signs

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight

Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

breast cancer
October 6, 2023/Cancer/Surgical Oncology

Surgical De-Escalation for Benign High-Risk Breast Lesions

Are we ready for ‘observation’ of lesions found on core needle biopsy?

23-CNR-4210969-CQD-Hero1-650×450 Dr Amarnath
October 6, 2023/Cancer/Research

Quality Metrics and Quality Improvement Program Can Improve Cervical Cancer Care

A new analysis emphasizes the value of a multi-disciplinary approach.

21-CHP-2315658-Hero-650×450
October 6, 2023/Cancer

New Consensus Statement Addresses Early Management of Ewing Sarcoma

Multicenter effort aims to standardize information about diagnosis and early management

23-CNR-42100966-CQD-Hero2-650×450 Dr Miller ASTRO article
October 5, 2023/Cancer/Research

Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma is Cost-Effective in Southern China

Use of MRI adds to cost but remains cost-effective due to higher sensitivity

23-CNR-4210967-CQD-Hero-Astro
October 4, 2023/Cancer/Research

Phase 1 Study Supports Dose-Escalating Preoperative SRS for Large Brain Metastases

This approach led to local control for patients with brain metastases more than 2 cm in diameter

BackPage 5 of 140Next

Advertisement

Ad